COPD with elevated sputum group 2 innate lymphoid cells is characterized by severe disease
Cameron H. Flayer, Angela L. Linderholm, Moyar Q. Ge, Maya Juarez, Lisa Franzi, Tina Tham, Melissa Teuber, Shu-Yi Liao, Michael Schivo, Brooks Kuhn, Amir Zeki, Angela Haczku
doi: https://doi.org/10.1101/2023.11.21.23298837
Cameron H. Flayer
1Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, USA
Angela L. Linderholm
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
Moyar Q. Ge
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
Maya Juarez
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
Lisa Franzi
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
Tina Tham
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
Melissa Teuber
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
Shu-Yi Liao
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
Michael Schivo
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
Brooks Kuhn
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
Amir Zeki
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
Angela Haczku
2Center for Comparative Respiratory Biology and Medicine, University of California, Davis, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted April 03, 2024.
COPD with elevated sputum group 2 innate lymphoid cells is characterized by severe disease
Cameron H. Flayer, Angela L. Linderholm, Moyar Q. Ge, Maya Juarez, Lisa Franzi, Tina Tham, Melissa Teuber, Shu-Yi Liao, Michael Schivo, Brooks Kuhn, Amir Zeki, Angela Haczku
medRxiv 2023.11.21.23298837; doi: https://doi.org/10.1101/2023.11.21.23298837
COPD with elevated sputum group 2 innate lymphoid cells is characterized by severe disease
Cameron H. Flayer, Angela L. Linderholm, Moyar Q. Ge, Maya Juarez, Lisa Franzi, Tina Tham, Melissa Teuber, Shu-Yi Liao, Michael Schivo, Brooks Kuhn, Amir Zeki, Angela Haczku
medRxiv 2023.11.21.23298837; doi: https://doi.org/10.1101/2023.11.21.23298837
Subject Area
Subject Areas
- Addiction Medicine (326)
- Allergy and Immunology (642)
- Anesthesia (170)
- Cardiovascular Medicine (2452)
- Dermatology (208)
- Emergency Medicine (384)
- Epidemiology (11896)
- Forensic Medicine (10)
- Gastroenterology (707)
- Genetic and Genomic Medicine (3829)
- Geriatric Medicine (356)
- Health Economics (646)
- Health Informatics (2470)
- Health Policy (954)
- Hematology (348)
- HIV/AIDS (806)
- Medical Education (379)
- Medical Ethics (105)
- Nephrology (409)
- Neurology (3595)
- Nursing (202)
- Nutrition (536)
- Oncology (1865)
- Ophthalmology (544)
- Orthopedics (228)
- Otolaryngology (293)
- Pain Medicine (235)
- Palliative Medicine (68)
- Pathology (457)
- Pediatrics (1057)
- Primary Care Research (432)
- Public and Global Health (6259)
- Radiology and Imaging (1317)
- Respiratory Medicine (842)
- Rheumatology (387)
- Sports Medicine (332)
- Surgery (418)
- Toxicology (51)
- Transplantation (177)
- Urology (149)